Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain
NCT06649747
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
408
Enrollment
INDUSTRY
Sponsor class
Conditions
Lumbosacral Radiculopathy
Interventions
DRUG:
AFA-281
Sponsor
Afasci Inc